The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Life Insurance Corporation of India (LIC) has disclosed the acquisition of 1,71,40,819 equity shares (2.054%) of Dr Reddys Laboratories Ltd through open market purchases between 3 June 2025 and 15 October 2025. This has taken LIC's total holding in the company from 6,85,59,072 shares (8.214%) to 8,56,99,891 shares (10.268%). LIC is not classified as a promoter or promoter group entity for Dr Reddys. The disclosure was filed under Regulation 29(2) of the SEBI Takeover Regulations, which is triggered whenever a non-promoter shareholder holding more than 5% crosses the 10% ownership mark.
This is a positive, confidence-inspiring signal — one of India's largest institutional investors has crossed the 10% ownership threshold in Dr Reddys, indicating long-term bullish conviction. Retail investors typically view such large institutional accumulation as supportive of the stock's price outlook, though LIC crossing 10% also means any further acquisitions above 5% in a financial year may trigger additional open-offer obligations under SEBI rules.